Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vaccine process technology-A decade of progress.

Biotechnology and bioengineering·2024

Same author

Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine.

Current opinion in chemical biology·2016

Same author

Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

Vaccine·2014

Same author

Vaccine Technology IV: an ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012.

Vaccine·2014

Same author

Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage.

Journal of pharmaceutical sciences·2014

Same author

Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process.

Biotechnology and bioengineering·2003

Search research articles

Related Experiment Video

Updated: May 24, 2026

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Vaccine process technology.

Jessica O Josefsberg¹, Barry Buckland

¹BioEdge Consulting, LLC, 100 Jefferson Avenue, Miami Beach, Florida, USA.

Biotechnology and Bioengineering

|March 13, 2012

Summary

This summary is machine-generated.

Vaccine technology and production methods have advanced together, creating safer, more effective vaccines. Innovations leverage biotechnology, improving stability, delivery, and manufacturing for global health needs.

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Related Experiment Videos

Last Updated: May 24, 2026

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Area of Science:

Biotechnology and immunology
Vaccine development and manufacturing

Background:

Vaccine evolution is intrinsically linked to advancements in production technologies.
Therapeutic protein development has spurred parallel innovations in vaccine technology.
Legacy vaccines are being improved for stability and formulation, while new technologies emerge.

Purpose of the Study:

To review the evolution of vaccine technologies and production methods.
To highlight modern vaccine development strategies and manufacturing advances.
To discuss regulatory considerations and future directions in vaccine innovation.

Main Methods:

Review of vaccine technologies including viral vectors, virus-like particles, polysaccharide conjugation, DNA plasmids, and cancer vaccines.
Discussion of purification and analytical method advancements.
Exploration of novel adjuvants and delivery systems.

Main Results:

Modern vaccine development employs diverse platforms like viral vectors, VLPs, and DNA plasmids.
Advances in purification and analytics enhance efficiency and process understanding.
Novel adjuvants and delivery methods improve vaccine efficacy and accessibility.

Conclusions:

Continued evolution of vaccine technology and production is crucial for developing safer, more immunogenic vaccines.
Biotechnology progress enables innovative vaccine solutions, including therapeutic cancer vaccines.
Focus on stability, cost-effectiveness, and novel delivery methods is key for global vaccine accessibility.